Publisher： Adis International
ISSN： 0114-9954
Source： Reactions Weekly, Vol.1, Iss.1240, 2009-01, pp. : 19-19
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adalimumab/efalizumab/infliximab: Psoriasis: 5 case reports
Reactions Weekly, Vol. 1, Iss. 1210, 2008-01 ,pp. :
Access to resources
Recommend
Efalizumab withdrawal/etanercept: Erythrodermic flare of plaque psoriasis: 3 case reports
Reactions Weekly, Vol. 1, Iss. 1220, 2008-01 ,pp. :
Efalizumab withdrawal: Psoriatic arthritis in patients with psoriasis: 2 case reports
Reactions Weekly, Vol. 1, Iss. 1154, 2007-01 ,pp. :
Efalizumab withdrawal: First report of bullous pemphigoid: case report
Reactions Weekly, Vol. 1, Iss. 1141, 2007-01 ,pp. :
Efalizumab/infliximab: CD8+ cutaneous T cell lymphoma (first report with efalizumab): 2 case reports
Reactions Weekly, Vol. 1, Iss. 1137, 2007-01 ,pp. :